Showing 21 - 40 results of 105 for search 'Hodgkin’s disease', query time: 0.05s Refine Results
  1. 21

    Occipital Hypometabolism on FDG PET/CT Scan in a Child with Hodgkin’s Lymphoma by Inci Uslu Biner, Ebru Tatci, Ozlem Ozmen, Atila Gokcek, Haci Ahmet Demir, Nadide Basak Gulleroglu

    Published 2016-01-01
    “…Here we described the fluorine-18 [18-F] FDG PET/CT imaging findings of encephalomalacia due to perinatal asphyxia in a child with refractory Hodgkin’s Lymphoma (HL) who underwent PET/CT scan to stage the primary disease. …”
    Get full text
    Article
  2. 22

    PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW by Maria Luisa Moleti, Anna Maria Testi

    Published 2024-10-01
    “… Pediatric Hodgkin lymphoma (HL) is a curable disease for more than 90% of children and adolescents in high income countries. …”
    Get full text
    Article
  3. 23

    Primary Bilateral Non-Hodgkin’s Lymphoma of the Adrenal Gland Presenting as Incidental Adrenal Masses by Christopher Rizzo, David James Camilleri, Alexandra Betts, Andre’ Gatt, Stephen Fava

    Published 2015-01-01
    “…During the diagnostic workup, imaging revealed bilateral large adrenal masses and she was later diagnosed with diffuse large B-cell non-Hodgkin’s lymphoma (DLBCL), with the adrenal glands being the dominant site of the disease. …”
    Get full text
    Article
  4. 24

    Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors by Maansi Joshi, Stephen M. Ansell

    Published 2020-01-01
    “…Non-Hodgkin lymphomas comprise a heterogenous group of disorders which differ in biology. …”
    Get full text
    Article
  5. 25

    Rapidly Progressing Refractory Hodgkin Lymphoma: A Case Report and a Possible Explanation by Ádám Jóna, Gábor Irsai, Sándor Barna, Gábor Méhes, Árpád Illés, László Váróczy

    Published 2016-01-01
    “…The authors present an unusually rapidly progressing case of refractory advanced stage classical nodular sclerosis subtype Hodgkin lymphoma with unfavorable prognosis. A 66-year-old male patient was refractory for first-line doxorubicin, bleomycin, vinblastin, dacarbazine (ABVD) treatment with persistent disease; therefore physicians changed treatment for dexamethasone, cytarabine, and cisplatin (DHAP) and later ifosfamide, gemcitabine, and vinorelbine (IGEV) regimen. …”
    Get full text
    Article
  6. 26

    Obstructive Jaundice as an Initial Manifestation of Non-Hodgkin Lymphoma: Treatment Dilemma and High Mortality by Dhara Chaudhari, Sarah Khan, Atif Saleem, Tamarro Taylor, Chakradhar Reddy, Thomas Borthwick, Mark Young

    Published 2013-01-01
    “…Introduction. Non Hodgkin lymphoma (NHL) presenting with obstructive jaundice is a rare occurrence. …”
    Get full text
    Article
  7. 27

    Prognostic Significance of Serum Proangiogenic Molecules in Patients with De Novo Non-Hodgkin Lymphomas by Pairaya Rujirojindakul, Arnuparp Lekhakula

    Published 2012-01-01
    “…Serum VEGF and bFGF concentrations were measured from 79 adult patients with newly diagnosed stage 2–4 non-Hodgkin lymphomas by quantitative sandwich enzyme immunoassay. …”
    Get full text
    Article
  8. 28
  9. 29
  10. 30

    A Case of Acute Hepatitis E Infection in a Patient with Non-Hodgkin Lymphoma Treated Successfully with Ribavirin by Hasan N. Y. Haboubi, Rizwan Diyar, Ann Benton, Chin Lye Ch’ng

    Published 2017-01-01
    “…We present the case of a man who, following immunosuppressive treatment for non-Hodgkin lymphoma, became infected with viral hepatitis E. …”
    Get full text
    Article
  11. 31

    Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma by Zhenhua Xian, Dehua Fu, Shuang Liu, Yang Yao, Chun Gao

    Published 2019-01-01
    “…Despite the overall success of using R-CHOP for the care for non-Hodgkin’s lymphoma patients, it is clear that the disease is quite complex and new insight is needed to further stratify the patient for a better personized treatment. …”
    Get full text
    Article
  12. 32

    Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Bas... by Fazıl Çağrı Hunutlu, Hikmet Öztop, Vildan Gürsoy, Tuba Ersal, Ezel Elgün, Şeyma Yavuz, Selin İldemir Ekizoğlu, Azim Ali Ekizoğlu, Vildan Özkocaman, Fahir Özkalemkaş

    Published 2025-01-01
    “…<b>Background:</b> Although the cure rates of classical Hodgkin Lymphoma (cHL) are as high as 90% using the current treatment protocols, the prognosis is poor for primary refractory patients. …”
    Get full text
    Article
  13. 33

    Successful Vaginal Delivery after Induction of Labour in a Patient Treated for Non-Hodgkin’s Lymphoma of the Cervix: A Case Report and Literature Review by Paola Quaresima, Gabriele Saccone, Valeria Zuccalà, Giuseppe Guarascio, Livio Leo, Giuseppina Amendola, Fulvio Zullo, Michele Morelli, Roberta Venturella

    Published 2022-01-01
    “…In carefully selected patients with fully treated non-Hodgkin’s lymphoma of the cervix with no residual disease, induction of labour via prostaglandins pessary may be a safe option if indicated.…”
    Get full text
    Article
  14. 34

    The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma by Eko A. Pangarsa, Ridho M. Naibaho, Vina Yunarvika, Budi Setiawan, Damai Santosa, Catharina Suharti

    Published 2021-01-01
    “…Up to 20–40% of patients with Hodgkin’s lymphoma will eventually relapse after treatment, among which early relapse confers a poor outcome. …”
    Get full text
    Article
  15. 35

    Complete Heart Block and Persistent Lactic Acidosis as an Initial Presentation of Non-Hodgkin Lymphoma in a Critically Ill Newly Diagnosed AIDS Patient by Mohsin Ijaz, Hassan Tariq, Masooma Niazi, Dmitry Lvovsky

    Published 2014-01-01
    “…Lactic acidosis and heart block as an initial presentation of non-Hodgkin lymphoma in an AIDS patient are an unusual and unique presentation.…”
    Get full text
    Article
  16. 36
  17. 37

    Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma by Shinya Ohata, Kei Takenaka, Daisuke Sugiyama, Takeshi Sugimoto

    Published 2022-01-01
    “…Bone marrow infiltration of lymphoma cells is a candidate risk factor for infusion-related reactions (IRRs) in patients with CD20-positive B-cell non-Hodgkin lymphoma (B-NHL). However, despite with the lack of sufficient data, the effect of bone marrow infiltration of B-NHL cells on the incidence rate of grade 2 or higher IRRs with the administration of rituximab has been retrospectively studied in this paper. …”
    Get full text
    Article
  18. 38

    Shared Medical and Environmental Risk Factors in Dry Eye Syndrome, Sjogren’s Syndrome, and B-Cell Non-Hodgkin Lymphoma: A Case-Control Study by Hadas Ben-Eli, Doron J. Aframian, Eldad Ben-Chetrit, Dror Mevorach, Geffen Kleinstern, Ora Paltiel, Abraham Solomon

    Published 2019-01-01
    “…To assess whether there are shared exposures associated with Sjogren’s syndrome (SS), dry eye syndrome (DES), and B-cell non-Hodgkin lymphoma (B-NHL), in order to determine whether they are etiologically related. …”
    Get full text
    Article
  19. 39

    Small cell lymphocytic lymphoma of eye annexes. Case presentation by Icilany Villares Álvarez, Julio Dámaso Fernández Águila, María de los A. García Dueñas, Alejandro Pérez Capote

    Published 2019-12-01
    “…A small B cell lymphocytic non-Hodgkin lymphoma was diagnosed by conjunctiva biopsy. …”
    Get full text
    Article
  20. 40

    Concurrent Liver Hodgkin Lymphoma and Nodular Regenerative Hyperplasia on an Explanted Liver with Clinical Diagnosis of Alcoholic Cirrhosis at University Hospital Fundación Santa F... by R. López, L. Barrera, A. Vera, R. Andrade

    Published 2014-01-01
    “…Liver involvement by Hodgkin lymphoma (HL) is well documented. However, secondary liver failure to this neoplastic process is rare and usually presents late in the course of the disease. …”
    Get full text
    Article